Skip to content

Stryker SYK Net Income

Net Income at other companies

Baxter International logo
Baxter InternationalBAX
-$15M-112%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$5.24B-52.4%
CONMED logo
CONMEDCNMD
$13.83M+129%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$41M+36.0%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
-$20.91M+60.6%
Boston Scientific logo
Boston ScientificBSX
$1.34B+99.3%

Other financials

Income statement

See full
Revenue$6.0B+2.6%
Gross profit$3.8B+1.8%
Operating income$936.0M+11.8%
EPS (diluted)$1.93+14.2%

Balance sheet

See full
Cash & equivalents$2.9B+24.1%
Total debt$14.4B-15.1%
Total assets$46.3B+0.6%

Cash flow

See full
Operating cash flow$581.0M+132%
CapEx$166.0M+35.0%
Free cash flow$415.0M+227%

Valuation

See full
Market cap$121.18B-15.6%
Enterprise value$132.69B-16.1%
P/E36.3×-13.9×
P/S4.8×-1.4×

Profitability

See full
Gross margin63.8%-0.1pp
Operating margin19.7%+4.4pp
Net margin13.2%+0.9pp
FCF margin18.1%+2.7pp

Returns & leverage

See full
Return on equity32.8%
Debt / equity0.8×
Current ratio2.1×+0.5×

Where this comes from

Reported directly by Stryker in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: Stryker’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Stryker's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Stryker's net income?
Stryker (SYK) reported net income of $745M in Q1 2026.
How has Stryker's net income changed year-over-year?
Stryker's net income increased by 13.9% year-over-year, from $654M to $745M.
What is the long-term trend for Stryker's net income?
Over 4 years (2021 to 2025), Stryker's net income has grown at a 13.0% compound annual growth rate (CAGR), from $1.99B to $3.25B.
What does net income mean?
The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.